Concord Drugs Limited (CONCORD.BO)
INR 36.45
(-2.72%)
INR 36.45
(-2.72%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 165.94 Million INR | -2.18% |
| 2022 | 169.64 Million INR | 3.23% |
| 2021 | 164.34 Million INR | 26.68% |
| 2020 | 129.73 Million INR | 35.59% |
| 2019 | 95.68 Million INR | -2.63% |
| 2018 | 98.26 Million INR | -27.87% |
| 2017 | 136.24 Million INR | -11.74% |
| 2016 | 154.36 Million INR | -22.77% |
| 2015 | 199.88 Million INR | -6.04% |
| 2014 | 212.73 Million INR | 22.93% |
| 2013 | 173.05 Million INR | 10.22% |
| 2012 | 157 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 173.47 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 165.94 Million INR | 0.0% |
| 2023 FY | 165.94 Million INR | -2.18% |
| 2022 FY | 169.64 Million INR | 3.23% |
| 2022 Q2 | 175.38 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 169.64 Million INR | 0.0% |
| 2021 Q2 | 111.01 Million INR | 0.0% |
| 2021 FY | 164.34 Million INR | 26.68% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 164.34 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q2 | 138.96 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 129.73 Million INR | 35.59% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 129.73 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 95.68 Million INR | -2.63% |
| 2019 Q4 | 95.68 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 98.27 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 127.89 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 98.26 Million INR | -27.87% |
| 2018 Q4 | 98.26 Million INR | 0.0% |
| 2017 Q4 | 136.24 Million INR | 0.0% |
| 2017 Q2 | 191.12 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 FY | 136.24 Million INR | -11.74% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 154.36 Million INR | -22.77% |
| 2016 Q4 | 198.89 Million INR | 0.0% |
| 2016 Q2 | 210.42 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 179.85 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 199.88 Million INR | -6.04% |
| 2015 Q4 | 199.88 Million INR | 0.0% |
| 2014 Q4 | 193.2 Million INR | 0.0% |
| 2014 Q2 | 171.04 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 FY | 212.73 Million INR | 22.93% |
| 2013 Q4 | 173.05 Million INR | 0.0% |
| 2013 FY | 173.05 Million INR | 10.22% |
| 2012 Q4 | 157 Million INR | 0.0% |
| 2012 FY | 157 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.56 Million INR | -549.134% |
| KIMIA BIOSCIENCES LIMITED | 437.07 Million INR | 62.033% |
| SHELTER PHARMA LIMITED | 5.77 Million INR | -2774.433% |
| Vasundhara Rasayans Limited | 19.46 Million INR | -752.51% |
| Sunil Healthcare Limited | 661.51 Million INR | 74.915% |
| Chemo Pharma Laboratories Limited | - INR | -Infinity% |
| MedPlus Health Services Limited | 10.09 Billion INR | 98.356% |
| Bharat Immunologicals & Biologicals Corporation Limited | 702.24 Million INR | 76.37% |
| Patidar Buildcon Limited | 25.32 Million INR | -555.298% |
| Roopa Industries Limited | 258.54 Million INR | 35.817% |
| Smruthi Organics Limited | 117.03 Million INR | -41.789% |
| Trident Lifeline Limited | 184.1 Million INR | 9.865% |
| PANJON LTD. | 14.36 Million INR | -1054.854% |
| Pharmaids Pharmaceuticals Limited | 85.32 Million INR | -94.474% |
| Gujarat Terce Laboratories Limited | 38.66 Million INR | -329.176% |
| TIAAN CONSUMER LIMITED | 14.8 Million INR | -1021.223% |
| Anuh Pharma Limited | 26.92 Million INR | -516.24% |
| Crestchem Limited | - INR | -Infinity% |
| Emmessar Biotech & Nutrition Limited | 1.09 Million INR | -15068.282% |
| Sandu Pharmaceuticals Limited | 633 Thousand INR | -26115.008% |
| Tyche Industries Limited | - INR | -Infinity% |
| Fredun Pharmaceuticals Limited | 1.05 Billion INR | 84.272% |
| Trimurthi Limited | - INR | -Infinity% |
| Shukra Pharmaceuticals Limited | 31.53 Million INR | -426.145% |
| Norris Medicines Limited | 215.23 Million INR | 22.903% |
| Zenlabs Ethica Limited | 148.59 Million INR | -11.673% |
| Vikram Thermo (India) Limited | 70.43 Million INR | -135.588% |
| ANG Lifesciences India Limited | 728.36 Million INR | 77.217% |
| Parmax Pharma Limited | 53.72 Million INR | -208.884% |
| Veerhealth Care Limited | - INR | -Infinity% |
| Deccan Health Care Limited | 18.95 Million INR | -775.632% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 84.172% |
| Makers Laboratories Limited | 194.92 Million INR | 14.868% |
| Lactose (India) Limited | 392.52 Million INR | 57.725% |
| OXYGENTA PHARMACEUTICAL LIMITE | 572.33 Million INR | 71.006% |
| Zenith Healthcare Limited | - INR | -Infinity% |
| Sanjivani Paranteral Limited. | 9.69 Million INR | -1612.321% |
| Bacil Pharma Limited | 984 Thousand INR | -16763.923% |
| PRAVEG LIMITED | 596.11 Million INR | 72.163% |
| Denis Chem Lab Limited | 10.46 Million INR | -1486.434% |
| Kwality Pharmaceuticals Limited | 981.19 Million INR | 83.088% |
| Jenburkt Pharmaceuticals Limited | - INR | -Infinity% |
| Colinz Laboratories Limited | 5.69 Million INR | -2812.267% |
| Godavari Drugs Limited | 556.24 Million INR | 70.168% |
| SHAMROCK INDUSTRIAL CO.LTD. | - INR | -Infinity% |
| Zenotech Laboratories Limited | - INR | -Infinity% |
| Panchsheel Organics Limited | 63.09 Million INR | -163.018% |
| Shree Ganesh Remedies Limited | 364.49 Million INR | 54.473% |
| Vivanza Biosciences Limited | 51.69 Million INR | -221.0% |
| Phaarmasia Limited | 1.44 Million INR | -11415.684% |
| Sastasundar Ventures Limited | 38.82 Million INR | -327.375% |
| Medi-Caps Limited | - INR | -Infinity% |
| DECIPHER LABS LIMITED | - INR | -Infinity% |
| Gujarat Themis Biosyn Limited | 27.68 Million INR | -499.411% |
| Ambalal Sarabhai Enterprises Limited | 461.12 Million INR | 64.014% |
| Mercury Laboratories Limited | 55.53 Million INR | -198.799% |
| Gennex Laboratories Limited | 57.2 Million INR | -190.081% |
| BDH Industries Limited | 86.9 Million INR | -90.941% |
| Coral Laboratories Limited | - INR | -Infinity% |
| Bharat Parenterals Limited | 1.57 Billion INR | 89.469% |
| Beryl Drugs Limited | 50.93 Million INR | -225.764% |
| Vista Pharmaceuticals Limited | 79.64 Million INR | -108.343% |
| Evoq Remedies Limited | 42.38 Million INR | -291.537% |
| Add-Shop E-Retail Limited | 127.73 Million INR | -29.906% |
| Transchem Limited | - INR | -Infinity% |
| Ishita Drugs and Industries Limited | - INR | -Infinity% |
| Parnax Lab Limited | 806.38 Million INR | 79.422% |
| Source Natural Foods and Herbal Supplements Limited | 35 Thousand INR | -474017.143% |
| Kerala Ayurveda Limited | 675.77 Million INR | 75.444% |
| Cian Healthcare Limited | 556.91 Million INR | 70.203% |
| Trinity League India Limited | 242 Thousand INR | -68470.661% |
| Syschem (India) Limited | 4.5 Million INR | -3587.578% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 88.121% |
| Natural Capsules Limited | 1.09 Billion INR | 84.777% |
| Auro Laboratories Limited | 262.43 Million INR | 36.769% |